Publications:26
Accepting New Patients
- Mount Sinai Doctors
- Accepting New Patients
Jonathan Anker, MD, PhD
Hematology-Oncology, Cancer (Oncology)
About Me
Jonathan Anker, MD, PhD, is Instructor of Medicine (Hematology and Medical Oncology) at the Icahn School of Medicine at Mount Sinai. He is a medical oncologist specializing in the care of patients with genitourinary cancers, including bladder, prostate, kidney, and testicular cancer. Dr. Anker's research focuses on tumor immunology and optimizing immunotherapeutics through laboratory, translational, and clinical studies.
Language
English
Position
INSTRUCTOR | Medicine, Hematology and Medical Oncology
Hospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
Research Topics
Cancer, Immunology
Clinical Focus
- Bladder Cancer
- Genitourinary Malignancies
- Germ Cell Tumors
- Kidney Cancer
- Prostate Cancer
- Renal Cancer
- Testicular Tumors
Education
BA, Dartmouth College
PhD, Northwestern University
MD, Northwestern University
Residency, Internal Medicine
Icahn School of Medicine at Mount Sinai
Fellowship, Hematology & Medical Oncology
Icahn School of Medicine at Mount Sinai
Certifications
American Board of Internal Medicine
Awards
2024
Innovation Prize
Mount Sinai
2024
Rapid Pilot Project Grant
Mount Sinai ConduITS CTSA
2024
Young Investigator Award
Bladder Cancer Advocacy Network
2024
Young Investigator Award
Conquer Cancer
2019
Alpha Omega Alpha Honor Medical Society
2018
Driskill Alumni Research Award
Northwestern University
2016
Ruth L. Kirschstein National Research Service Award (F30)
National Cancer Institute
2011
Rufus Choate Scholar
Dartmouth College
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
- AETNA - Commercial
- AETNA - Medicare
- CIGNA Healthcare
- Centivo
- EmblemHealth - GHI-PPO
- EmblemHealth - HIP-Medicare
- HealthFirst Medicare
- Horizon NJ
- Oscar
- Oxford - Freedom and Liberty
- United Health Care - Oxford Care
- United Health Care - Top Tier
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Atezolizumab plus personalized neoantigen vaccination in urothelial cancer: a phase 1 trial. Mansi Saxena, Jonathan F. Anker, Julia Kodysh, Timothy O’Donnell, Anna M. Kaminska, Marcia Meseck, Olivia Hapanowicz, Scot Anthony Niglio, Andres M. Salazar, Hardik R. Shah, Yayoi Kinoshita, Rachel Brody, Alex Rubinsteyn, Robert P. Sebra, Nina Bhardwaj, Matthew D. Galsky. Nature Cancer
- Characterization of Exceptional Responses in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Cabozantinib and Immune Checkpoint Inhibitors. Teja Ganta, Jonathan F. Anker, Eric Miller, Himanshu Joshi, Che Kai Tsao, William K. Oh. Clinical Genitourinary Cancer
- Different PD-L1 Assays Reveal Distinct Immunobiology and Clinical Outcomes in Urothelial Cancer. Matthew D. Galsky, Mark Kockx, Juliette Roels, Roos Van Elzen, Xiangnan Guan, Kobe Yuen, Deepali Rishipathak, Jonathan F. Anker, Sacha Gnjatic, Sudeh Izadmehr, Shomyseh Sanjabi, Robert J. Johnston, Maureen Peterson, Hartmut Koeppen, Justin M. David, Saurabh Gupta, Aristotelis Bamias, Jose Angel Arranz, Eiji Kikuchi, Maria De Santis, Ian D. Davis, Patrick Williams, Sandrine Bernhard, Ira Mellman, Enrique Grande, Romain Banchereau, Sanjeev Mariathasan. Cancer Immunology Research
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Anker during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
- IntrinsiQ Specialty Solutions
- Curio Science
- MJH Life Sciences
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.